{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T10:10:13Z","timestamp":1790763013964,"version":"4.1.0"},"reference-count":115,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Biochemistry"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1016\/j.clinbiochem.2019.07.010","type":"journal-article","created":{"date-parts":[[2019,7,25]],"date-time":"2019-07-25T20:30:23Z","timestamp":1564086623000},"page":"1-10","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":47,"special_numbering":"C","title":["The epigenetic regulation of paraoxonase 1 (PON1) as an important enzyme in HDL function: The missing link between environmental and genetic regulation"],"prefix":"10.1016","volume":"73","author":[{"given":"Abdolkarim","family":"Mahrooz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mike","family":"Mackness","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abouzar","family":"Bagheri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Ghaffari-Cherati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parisa","family":"Masoumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.clinbiochem.2019.07.010_bb0005","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1161\/01.ATV.21.4.473","article-title":"Paraoxonase and atherosclerosis","volume":"21","author":"Durrington","year":"2001","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"1","key":"10.1016\/j.clinbiochem.2019.07.010_bb0010","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.freeradbiomed.2010.10.708","article-title":"Human carotid lesion linoleic acid hydroperoxide inhibits paraoxonase 1 (PON1) activity via reaction with PON1 free sulfhydryl cysteine 284","volume":"50","author":"Tavori","year":"2011","journal-title":"Free Radic. Biol. Med."},{"issue":"1","key":"10.1016\/j.clinbiochem.2019.07.010_bb0015","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.gene.2015.04.088","article-title":"Human paraoxonase-1 (PON1): gene structure and expression, promiscuous activities and multiple physiological roles","volume":"567","author":"Mackness","year":"2015","journal-title":"Gene"},{"key":"10.1016\/j.clinbiochem.2019.07.010_bb0020","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.cbi.2016.05.036","article-title":"Paraoxonases-1,-2 and-3: what are their functions?","volume":"259","author":"Furlong","year":"2016","journal-title":"Chem. Biol. Interact."},{"issue":"5","key":"10.1016\/j.clinbiochem.2019.07.010_bb0025","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1038\/nsmb767","article-title":"Structure and evolution of the serum paraoxonase family of detoxifying and anti-atherosclerotic enzymes","volume":"11","author":"Harel","year":"2004","journal-title":"Nat. Struct. Mol. Biol."},{"issue":"1","key":"10.1016\/j.clinbiochem.2019.07.010_bb0030","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.atherosclerosis.2010.08.076","article-title":"The three-gene paraoxonase family: physiologic roles, actions and regulation","volume":"214","author":"Pr\u00e9court","year":"2011","journal-title":"Atherosclerosis"},{"issue":"6","key":"10.1016\/j.clinbiochem.2019.07.010_bb0035","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1194\/jlr.M400511-JLR200","article-title":"Human paraoxonases (PON1, PON2, and PON3) are lactonases with overlapping and distinct substrate specificities","volume":"46","author":"Draganov","year":"2005","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.clinbiochem.2019.07.010_bb0040","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.atherosclerosis.2018.11.004","article-title":"The combined utility of myeloperoxidase (MPO) and paraoxonase 1 (PON1) as two important HDL-associated enzymes in coronary artery disease: which has a stronger predictive role?","volume":"280","author":"Variji","year":"2019","journal-title":"Atherosclerosis"},{"issue":"8","key":"10.1016\/j.clinbiochem.2019.07.010_bb0045","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1016\/j.freeradbiomed.2012.01.019","article-title":"Purified human paraoxonase-1 interacts with plasma membrane lipid rafts and mediates cholesterol efflux from macrophages","volume":"52","author":"Berrougui","year":"2012","journal-title":"Free Radic. Biol. Med."},{"issue":"1","key":"10.1016\/j.clinbiochem.2019.07.010_bb0050","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.ymgme.2011.09.018","article-title":"Association between PON1 activity and coronary heart disease risk: a meta-analysis based on 43 studies","volume":"105","author":"Zhao","year":"2012","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.clinbiochem.2019.07.010_bb0055","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.atherosclerosis.2015.12.021","article-title":"Serum paraoxonase-1 activity and risk of incident cardiovascular disease: the prevend study and meta-analysis of prospective population studies","volume":"245","author":"Kunutsor","year":"2016","journal-title":"Atherosclerosis"},{"issue":"3","key":"10.1016\/j.clinbiochem.2019.07.010_bb0060","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.ccl.2010.04.005","article-title":"The genetics of vascular complications in diabetes mellitus","volume":"28","author":"Farbstein","year":"2010","journal-title":"Cardiol. Clin."},{"issue":"2","key":"10.1016\/j.clinbiochem.2019.07.010_bb0065","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1080\/10408360802610878","article-title":"The paraoxonases: role in human diseases and methodological difficulties in measurement","volume":"46","author":"Camps","year":"2009","journal-title":"Crit. Rev. Clin. Lab. Sci."},{"issue":"4","key":"10.1016\/j.clinbiochem.2019.07.010_bb0070","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.trsl.2009.01.007","article-title":"Atorvastatin effect on the distribution of high-density lipoprotein subfractions and human paraoxonase activity","volume":"153","author":"Harangi","year":"2009","journal-title":"Transl. Res."},{"issue":"3","key":"10.1016\/j.clinbiochem.2019.07.010_bb0075","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1111\/j.1365-2362.2009.02090.x","article-title":"Serum paraoxonase-I activity is unaffected by short-term administration of simvastatin, bezafibrate, and their combination in type 2 diabetes mellitus","volume":"39","author":"Dullaart","year":"2009","journal-title":"Eur. J. Clin. Investig."},{"issue":"6","key":"10.1016\/j.clinbiochem.2019.07.010_bb0080","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1097\/FPC.0b013e3280925716","article-title":"Pharmacogenetic interaction between paraoxonase-1 gene promoter polymorphism C-107T and statin","volume":"17","author":"Deakin","year":"2007","journal-title":"Pharmacogenet. Genomics"},{"issue":"35","key":"10.1016\/j.clinbiochem.2019.07.010_bb0085","doi-asserted-by":"crossref","first-page":"12780","DOI":"10.1073\/pnas.0805865105","article-title":"Engineered recombinant human paraoxonase 1 (rHuPON1) purified from Escherichia coli protects against organophosphate poisoning","volume":"105","author":"Stevens","year":"2008","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"12","key":"10.1016\/j.clinbiochem.2019.07.010_bb0090","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.2217\/pgs.13.147","article-title":"Pharmacogenetics of paraoxonase activity: elucidating the role of high-density lipoprotein in disease","volume":"14","author":"Kim","year":"2013","journal-title":"Pharmacogenomics"},{"issue":"3","key":"10.1016\/j.clinbiochem.2019.07.010_bb0095","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1038\/sj.bjp.0707585","article-title":"Paraoxonase 1 gene transfer lowers vascular oxidative stress and improves vasomotor function in apolipoprotein E-deficient mice with pre-existing atherosclerosis","volume":"153","author":"Guns","year":"2008","journal-title":"Br. J. Pharmacol."},{"issue":"6","key":"10.1016\/j.clinbiochem.2019.07.010_bb0100","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1021\/mp800113g","article-title":"IgG-Paraoxonase-1 fusion protein for targeted drug delivery across the human blood\u2212 brain barrier","volume":"5","author":"Boado","year":"2008","journal-title":"Mol. Pharm."},{"issue":"6a","key":"10.1016\/j.clinbiochem.2019.07.010_bb0105","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1111\/j.1582-4934.2010.01022.x","article-title":"Epigenetics in atherosclerosis and inflammation","volume":"14","author":"Wierda","year":"2010","journal-title":"J. Cell. Mol. Med."},{"issue":"7143","key":"10.1016\/j.clinbiochem.2019.07.010_bb0110","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1038\/nature05919","article-title":"Phenotypic plasticity and the epigenetics of human disease","volume":"447","author":"Feinberg","year":"2007","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.clinbiochem.2019.07.010_bb0115","doi-asserted-by":"crossref","first-page":"122","DOI":"10.11613\/BM.2011.020","article-title":"The paraoxonase 1, 2 and 3 in humans","volume":"21","author":"Grdic Rajkovic","year":"2011","journal-title":"Biochem. Med."},{"issue":"1","key":"10.1016\/j.clinbiochem.2019.07.010_bb0120","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s11869-010-0095-2","article-title":"Air pollution and circulating biomarkers of oxidative stress","volume":"4","author":"Delfino","year":"2011","journal-title":"Air Qual. Atmos. Health"},{"issue":"1","key":"10.1016\/j.clinbiochem.2019.07.010_bb0125","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1038\/s41598-017-00384-5","article-title":"Persistent DNA methylation changes associated with prenatal mercury exposure and cognitive performance during childhood","volume":"7","author":"Cardenas","year":"2017","journal-title":"Sci. Rep."},{"issue":"1\u20132","key":"10.1016\/j.clinbiochem.2019.07.010_bb0130","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.cca.2008.12.019","article-title":"Validation of PON1 enzyme activity assays for longitudinal studies","volume":"402","author":"Huen","year":"2009","journal-title":"Clin. Chim. Acta"},{"issue":"16","key":"10.1016\/j.clinbiochem.2019.07.010_bb0135","doi-asserted-by":"crossref","first-page":"6371","DOI":"10.1021\/bi047440d","article-title":"Structure\u2212 reactivity studies of serum paraoxonase PON1 suggest that its native activity is lactonase","volume":"44","author":"Khersonsky","year":"2005","journal-title":"Biochemistry"},{"issue":"10","key":"10.1016\/j.clinbiochem.2019.07.010_bb0140","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1016\/S0960-894X(03)00290-7","article-title":"Structure\u2013activity relationship on human serum paraoxonase (PON1) using substrate analogues and inhibitors","volume":"13","author":"Bargota","year":"2003","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"1","key":"10.1016\/j.clinbiochem.2019.07.010_bb0145","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1515\/CCLM.2011.004","article-title":"Serum paraoxonase 1 (PON1) lactonase activity is lower in end-stage renal disease patients than in healthy control subjects and increases after hemodialysis","volume":"49","author":"Gugliucci","year":"2011","journal-title":"Clin. Chem. Lab. Med."},{"issue":"1","key":"10.1016\/j.clinbiochem.2019.07.010_bb0150","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.freeradbiomed.2010.09.002","article-title":"HDL-associated paraoxonase-1 can redistribute to cell membranes and influence sensitivity to oxidative stress","volume":"50","author":"Deakin","year":"2011","journal-title":"Free Radic. Biol. Med."},{"issue":"6","key":"10.1016\/j.clinbiochem.2019.07.010_bb0155","doi-asserted-by":"crossref","first-page":"2512","DOI":"10.1128\/IAI.01606-07","article-title":"Dominant role of paraoxonases in inactivation of the Pseudomonas aeruginosa quorum-sensing signal N-(3-oxododecanoyl)-L-homoserine lactone","volume":"76","author":"Teiber","year":"2008","journal-title":"Infect. Immun."},{"issue":"1","key":"10.1016\/j.clinbiochem.2019.07.010_bb0160","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.bbrc.2018.09.083","article-title":"Identification of biologically active \u03b4-lactone eicosanoids as paraoxonase substrates","volume":"505","author":"Teiber","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"9","key":"10.1016\/j.clinbiochem.2019.07.010_bb0165","first-page":"1118","article-title":"5, 6-\u03b4-DHTL, a stable metabolite of arachidonic acid, is a potential substrate for paraoxonase 1","volume":"1851","author":"Eryanni-Levin","year":"2015","journal-title":"Biochim. Biophys. Acta (BBA)-Mol. Cell Biol. Lipids"},{"issue":"3","key":"10.1016\/j.clinbiochem.2019.07.010_bb0170","first-page":"386","article-title":"Paraoxonase 1 in endothelial cells impairs vasodilation induced by arachidonic acid lactone metabolite","volume":"1864","author":"Gilad","year":"2019","journal-title":"Biochim. Biophys. Acta (BBA)-Mol. Cell Biol. Lipids"},{"issue":"4","key":"10.1016\/j.clinbiochem.2019.07.010_bb0175","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.carpath.2007.10.001","article-title":"Paraoxonase-1 deficiency in mice predisposes to vascular inflammation, oxidative stress, and thrombogenicity in the absence of hyperlipidemia","volume":"17","author":"Ng","year":"2008","journal-title":"Cardiovasc. Pathol."},{"issue":"3","key":"10.1016\/j.clinbiochem.2019.07.010_bb0180","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1021\/jacs.6b10801","article-title":"Active site hydrophobicity and the convergent evolution of paraoxonase activity in structurally divergent enzymes: the case of serum paraoxonase 1","volume":"139","author":"Blaha-Nelson","year":"2017","journal-title":"J. Am. Chem. Soc."},{"issue":"10","key":"10.1016\/j.clinbiochem.2019.07.010_bb0185","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1161\/01.ATV.18.10.1617","article-title":"Paraoxonase active site required for protection against LDL oxidation involves its free sulfhydryl group and is different from that required for its arylesterase\/paraoxonase activities: selective action of human paraoxonase allozymes Q and R","volume":"18","author":"Aviram","year":"1998","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"4","key":"10.1016\/j.clinbiochem.2019.07.010_bb0190","doi-asserted-by":"crossref","first-page":"309","DOI":"10.2486\/indhealth.46.309","article-title":"Interethnic variability of plasma Paraoxonase (PON1) activity towards organophosphates and PON1 polymorphisms among Asian populations\u2501 a short review","volume":"46","author":"Ali","year":"2008","journal-title":"Ind. Health"},{"key":"10.1016\/j.clinbiochem.2019.07.010_bb0195","article-title":"Insights into the mechanism of paraoxonase-1: comparing the reactivity of the six-bladed \u03b2-propeller hydrolases","author":"Grunkemeyer","year":"2018","journal-title":"Biochemistry"},{"issue":"3","key":"10.1016\/j.clinbiochem.2019.07.010_bb0200","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1006\/geno.1996.0401","article-title":"Structural organization of the HumanPON1Gene","volume":"35","author":"Clendenning","year":"1996","journal-title":"Genomics"},{"issue":"5","key":"10.1016\/j.clinbiochem.2019.07.010_bb0205","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1042\/CS20040187","article-title":"Genetic and environmental factors modulating serum concentrations and activities of the antioxidant enzyme paraoxonase-1","volume":"107","author":"Deakin","year":"2004","journal-title":"Clin. Sci."},{"issue":"11","key":"10.1016\/j.clinbiochem.2019.07.010_bb0210","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1161\/01.ATV.0000096207.01487.36","article-title":"Simvastatin modulates expression of the PON1 gene and increases serum paraoxonase: a role for sterol regulatory element\u2013binding protein-2","volume":"23","author":"Deakin","year":"2003","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"4","key":"10.1016\/j.clinbiochem.2019.07.010_bb0215","doi-asserted-by":"crossref","first-page":"259","DOI":"10.2174\/1574884711666160915153433","article-title":"Pharmacological interactions of paraoxonase 1 (PON1): a HDL-bound antiatherogenic enzyme","volume":"11","author":"Mahrooz","year":"2016","journal-title":"Curr. Clin. Pharmacol."},{"key":"10.1016\/j.clinbiochem.2019.07.010_bb0220","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.tox.2012.07.011","article-title":"Paraoxonase 1 (PON1) as a genetic determinant of susceptibility to organophosphate toxicity","volume":"307","author":"Costa","year":"2013","journal-title":"Toxicology"},{"issue":"2","key":"10.1016\/j.clinbiochem.2019.07.010_bb0225","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1194\/jlr.P033266","article-title":"Novel common and rare genetic determinants of paraoxonase activity: FTO, SERPINA12, and ITGAL","volume":"54","author":"Kim","year":"2013","journal-title":"J. Lipid Res."},{"issue":"14","key":"10.1016\/j.clinbiochem.2019.07.010_bb0230","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1177\/1535370216641786","article-title":"The common variant Q192R at the paraoxonase 1 (PON1) gene and its activity are responsible for a portion of the altered antioxidant status in type 2 diabetes","volume":"241","author":"Zargari","year":"2016","journal-title":"Exp. Biol. Med."},{"issue":"1","key":"10.1016\/j.clinbiochem.2019.07.010_bb0235","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0014-5793(98)00064-7","article-title":"Effect of the human serum paraoxonase 55 and 192 genetic polymorphisms on the protection by high density lipoprotein against low density lipoprotein oxidative modification","volume":"423","author":"Mackness","year":"1998","journal-title":"FEBS Lett."},{"issue":"1\u20132","key":"10.1016\/j.clinbiochem.2019.07.010_bb0240","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.jns.2014.01.006","article-title":"The salt stimulation property of serum paraoxonase (PON1) could be a valuable factor in evaluating the enzyme status in ischemic stroke: the role of activity-determined PON1 192Q\/R phenotypes","volume":"338","author":"Mahrooz","year":"2014","journal-title":"J. Neurol. Sci."},{"issue":"3","key":"10.1016\/j.clinbiochem.2019.07.010_bb0245","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1038\/ng1196-334","article-title":"The effect of the human serum paraoxonase polymorphism is reversed with diazoxon, soman and sarin","volume":"14","author":"Davies","year":"1996","journal-title":"Nat. Genet."},{"issue":"11","key":"10.1016\/j.clinbiochem.2019.07.010_bb0250","doi-asserted-by":"crossref","first-page":"2492","DOI":"10.1194\/jlr.M600297-JLR200","article-title":"The 192R\/Q polymorphs of serum paraoxonase PON1 differ in HDL binding, lipolactonase stimulation, and cholesterol efflux","volume":"47","author":"Gaidukov","year":"2006","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.clinbiochem.2019.07.010_bb0255","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.cca.2018.05.037","article-title":"Paraoxonase 1 (PON1)-L55M among common variants in the coding region of the paraoxonase gene family may contribute to the glycemic control in type 2 diabetes","volume":"484","author":"Mahrooz","year":"2018","journal-title":"Clin. Chim. Acta"},{"issue":"4","key":"10.1016\/j.clinbiochem.2019.07.010_bb0260","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/S0022-2275(20)31161-5","article-title":"Decreased stability of the M54 isoform of paraoxonase as a contributory factor to variations in human serum paraoxonase concentrations","volume":"42","author":"Leviev","year":"2001","journal-title":"J. Lipid Res."},{"issue":"4","key":"10.1016\/j.clinbiochem.2019.07.010_bb0265","doi-asserted-by":"crossref","first-page":"e96","DOI":"10.1097\/00006676-200405000-00021","article-title":"Association of Paraoxonase 1 polymorphism with Beta-cell function: a case of molecular Heterosis","volume":"28","author":"Chiu","year":"2004","journal-title":"Pancreas"},{"issue":"13","key":"10.1016\/j.clinbiochem.2019.07.010_bb0270","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/j.clinbiochem.2017.04.016","article-title":"Paraoxonases and infectious diseases","volume":"50","author":"Camps","year":"2017","journal-title":"Clin. Biochem."},{"issue":"2","key":"10.1016\/j.clinbiochem.2019.07.010_bb0275","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.atherosclerosis.2004.05.029","article-title":"Roles of Sp1 and protein kinase C in regulation of human serum paraoxonase 1 (PON1) gene transcription in HepG2 cells","volume":"176","author":"Osaki","year":"2004","journal-title":"Atherosclerosis"},{"issue":"11","key":"10.1016\/j.clinbiochem.2019.07.010_bb0280","doi-asserted-by":"crossref","first-page":"2450","DOI":"10.1194\/jlr.P030601","article-title":"Dietary cholesterol increases paraoxonase 1 enzyme activity","volume":"53","author":"Kim","year":"2012","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.clinbiochem.2019.07.010_bb0285","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/476316","article-title":"Additional common Polymorphisms in the PON Gene Cluster Predict PON1 activity but not vascular Disease","volume":"2012","author":"Kim","year":"2012","journal-title":"J. Lipids"},{"issue":"1","key":"10.1016\/j.clinbiochem.2019.07.010_bb0290","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/nm.2281","article-title":"Paraoxonase-1 is a major determinant of clopidogrel efficacy","volume":"17","author":"Bouman","year":"2011","journal-title":"Nat. Med."},{"issue":"2","key":"10.1016\/j.clinbiochem.2019.07.010_bb0295","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1021\/tx2004085","article-title":"Cytochromes P450 catalyze both steps of the major pathway of clopidogrel bioactivation, whereas paraoxonase catalyzes the formation of a minor thiol metabolite isomer","volume":"25","author":"Dansette","year":"2011","journal-title":"Chem. Res. Toxicol."},{"issue":"9","key":"10.1016\/j.clinbiochem.2019.07.010_bb0300","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1038\/nm.2386","article-title":"Paraoxonase-1 and clopidogrel efficacy","volume":"17","author":"Camps","year":"2011","journal-title":"Nat. Med."},{"issue":"9","key":"10.1016\/j.clinbiochem.2019.07.010_bb0305","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1038\/nm.2436","article-title":"Paraoxonase-1 and clopidogrel efficacy","volume":"17","author":"Dansette","year":"2011","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.clinbiochem.2019.07.010_bb0310","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/S0090-9556(25)07065-5","article-title":"Purification of human serum paraoxonase\/arylesterase. Evidence for one esterase catalyzing both activities","volume":"19","author":"Gan","year":"1991","journal-title":"Drug Metab. Dispos."},{"issue":"16","key":"10.1016\/j.clinbiochem.2019.07.010_bb0315","doi-asserted-by":"crossref","first-page":"7187","DOI":"10.1073\/pnas.92.16.7187","article-title":"Reconsideration of the catalytic center and mechanism of mammalian paraoxonase\/arylesterase","volume":"92","author":"Sorenson","year":"1995","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"11","key":"10.1016\/j.clinbiochem.2019.07.010_bb0320","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1016\/j.bcp.2005.09.002","article-title":"Butyrylcholinesterase, paraoxonase, and albumin esterase, but not carboxylesterase, are present in human plasma","volume":"70","author":"Li","year":"2005","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.clinbiochem.2019.07.010_bb0325","series-title":"Paraoxonase (PON1) in Health and Disease: basic and Clinical Aspects","author":"Costa","year":"2002"},{"key":"10.1016\/j.clinbiochem.2019.07.010_bb0330","series-title":"The Paraoxonases: their Role in Disease Development and Xenobiotic Metabolism","author":"Mackness","year":"2007"},{"issue":"1","key":"10.1016\/j.clinbiochem.2019.07.010_bb0335","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.molmed.2009.11.003","article-title":"Epigenetics: molecular mechanisms and implications for disease","volume":"16","author":"Handel","year":"2010","journal-title":"Trends Mol. Med."},{"issue":"12","key":"10.1016\/j.clinbiochem.2019.07.010_bb0340","doi-asserted-by":"crossref","first-page":"2718","DOI":"10.2337\/db09-1003","article-title":"Epigenetics: a molecular link between environmental factors and type 2 diabetes","volume":"58","author":"Ling","year":"2009","journal-title":"Diabetes"},{"issue":"7299","key":"10.1016\/j.clinbiochem.2019.07.010_bb0345","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1038\/nature09230","article-title":"Epigenetics as a unifying principle in the aetiology of complex traits and diseases","volume":"465","author":"Petronis","year":"2010","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.clinbiochem.2019.07.010_bb0350","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1097\/MOP.0000000000000192","article-title":"Recent progress in the genetics and epigenetics of paraoxonase: why it is relevant to children's environmental health","volume":"27","author":"Holland","year":"2015","journal-title":"Curr. Opin. Pediatr."},{"issue":"Suppl. 1","key":"10.1016\/j.clinbiochem.2019.07.010_bb0355","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1159\/000178030","article-title":"Is epigenetics an important link between early life events and adult disease?","volume":"71","author":"Waterland","year":"2009","journal-title":"Hormone Res. Paediatr."},{"issue":"9","key":"10.1016\/j.clinbiochem.2019.07.010_bb0360","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1038\/nrcardio.2010.104","article-title":"Epigenetics and cardiovascular disease","volume":"7","author":"Ordov\u00e1s","year":"2010","journal-title":"Nat. Rev. Cardiol."},{"issue":"2","key":"10.1016\/j.clinbiochem.2019.07.010_bb0365","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.jnutbio.2013.09.016","article-title":"The regulation of hepatic Pon1 by a maternal high-fat diet is gender specific and may occur through promoter histone modifications in neonatal rats","volume":"25","author":"Strakovsky","year":"2014","journal-title":"J. Nutr. Biochem."},{"issue":"9","key":"10.1016\/j.clinbiochem.2019.07.010_bb0370","doi-asserted-by":"crossref","first-page":"a019505","DOI":"10.1101\/cshperspect.a019505","article-title":"Epigenetic determinants of cancer","volume":"8","author":"Baylin","year":"2016","journal-title":"Cold Spring Harb. Perspect. Biol."},{"issue":"4","key":"10.1016\/j.clinbiochem.2019.07.010_bb0375","doi-asserted-by":"crossref","first-page":"a018713","DOI":"10.1101\/cshperspect.a018713","article-title":"Erasers of histone acetylation: the histone deacetylase enzymes","volume":"6","author":"Seto","year":"2014","journal-title":"Cold Spring Harb. Perspect. Biol."},{"issue":"8","key":"10.1016\/j.clinbiochem.2019.07.010_bb0380","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1038\/nrg.2016.59","article-title":"The molecular hallmarks of epigenetic control","volume":"17","author":"Allis","year":"2016","journal-title":"Nat. Rev. Genet."},{"issue":"5","key":"10.1016\/j.clinbiochem.2019.07.010_bb0385","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1111\/j.1365-2796.2007.01777.x","article-title":"Impact of inflammation on epigenetic DNA methylation\u2013a novel risk factor for cardiovascular disease?","volume":"261","author":"Stenvinkel","year":"2007","journal-title":"J. Intern. Med."},{"issue":"9","key":"10.1016\/j.clinbiochem.2019.07.010_bb0390","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1016\/j.bbagen.2009.02.008","article-title":"Epigenetics and atherosclerosis","volume":"1790","author":"Turunen","year":"2009","journal-title":"Biochim. Biophys. Acta (BBA)-Gen. Subjects"},{"issue":"8","key":"10.1016\/j.clinbiochem.2019.07.010_bb0395","doi-asserted-by":"crossref","first-page":"2406S","DOI":"10.1093\/jn\/132.8.2406S","article-title":"DNA methylation and atherosclerosis","volume":"132","author":"Dong","year":"2002","journal-title":"J. Nutr."},{"issue":"4","key":"10.1016\/j.clinbiochem.2019.07.010_bb0400","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.arr.2009.04.001","article-title":"PON1 is a longevity gene: results of a meta-analysis","volume":"8","author":"Lescai","year":"2009","journal-title":"Ageing Res. Rev."},{"issue":"10","key":"10.1016\/j.clinbiochem.2019.07.010_bb0405","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1139\/cjpp-2017-0117","article-title":"The role of paraoxonase 1 in regulating HDL functionality during aging","volume":"95","author":"Khalil","year":"2017","journal-title":"Can. J. Physiol. Pharmacol."},{"issue":"6","key":"10.1016\/j.clinbiochem.2019.07.010_bb0410","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1093\/gerona\/61.6.541","article-title":"Paraoxonase activity and genotype predispose to successful aging","volume":"61","author":"Marchegiani","year":"2006","journal-title":"J. Gerontol. Ser. A Biol. Med. Sci."},{"issue":"10","key":"10.1016\/j.clinbiochem.2019.07.010_bb0415","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1101\/gad.2037511","article-title":"CpG islands and the regulation of transcription","volume":"25","author":"Deaton","year":"2011","journal-title":"Genes Dev."},{"issue":"5","key":"10.1016\/j.clinbiochem.2019.07.010_bb0420","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1097\/MOL.0b013e3283309928","article-title":"Atherosclerosis risk factors can impose aberrant DNA methylation patterns: a tale of traffic and homocysteine","volume":"20","author":"Lund","year":"2009","journal-title":"Curr. Opin. Lipidol."},{"key":"10.1016\/j.clinbiochem.2019.07.010_bb0425","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1038\/nrendo.2009.102","article-title":"Epigenetic mechanisms that underpin metabolic and cardiovascular diseases","volume":"5","author":"Gluckman","year":"2009","journal-title":"Nat. Rev. Endocrinol."},{"issue":"1","key":"10.1016\/j.clinbiochem.2019.07.010_bb0430","doi-asserted-by":"crossref","DOI":"10.1093\/eep\/dvv003","article-title":"PON1 as a model for integration of genetic, epigenetic, and expression data on candidate susceptibility genes","volume":"1","author":"Huen","year":"2015","journal-title":"Environ. Epigen."},{"issue":"2","key":"10.1016\/j.clinbiochem.2019.07.010_bb0435","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s13105-014-0316-5","article-title":"Epigenetic patterns of two gene promoters (TNF-\u03b1 and PON) in stroke considering obesity condition and dietary intake","volume":"70","author":"G\u00f3mez-Uriz","year":"2014","journal-title":"J. Physiol. Biochem."},{"issue":"1","key":"10.1016\/j.clinbiochem.2019.07.010_bb0440","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s13148-017-0336-4","article-title":"Interaction between prenatal pesticide exposure and a common polymorphism in the PON1 gene on DNA methylation in genes associated with cardio-metabolic disease risk\u2014an exploratory study","volume":"9","author":"Declerck","year":"2017","journal-title":"Clin. Epigenetics"},{"key":"10.1016\/j.clinbiochem.2019.07.010_bb0445","first-page":"416","article-title":"Arylesterase activity is associated with antioxidant intake and paraoxonase-1 (pon1) gene methylation in metabolic syndrome patients following an energy restricted diet","volume":"13","author":"de la Iglesia","year":"2014","journal-title":"EXCLI J."},{"issue":"1","key":"10.1016\/j.clinbiochem.2019.07.010_bb0450","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1186\/1471-2164-15-860","article-title":"Genetic and epigenetic regulation of gene expression in fetal and adult human livers","volume":"15","author":"Bonder","year":"2014","journal-title":"BMC Genomics"},{"issue":"1","key":"10.1016\/j.clinbiochem.2019.07.010_bb0455","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1868-7083-4-6","article-title":"A macroepigenetic approach to identify factors responsible for the autism epidemic in the United States","volume":"4","author":"Dufault","year":"2012","journal-title":"Clin. Epigenetics"},{"issue":"1","key":"10.1016\/j.clinbiochem.2019.07.010_bb0460","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1476-511X-5-1","article-title":"Mining literature for a comprehensive pathway analysis: a case study for retrieval of homocysteine related genes for genetic and epigenetic studies","volume":"5","author":"Sharma","year":"2006","journal-title":"Lipids Health Dis."},{"issue":"1","key":"10.1016\/j.clinbiochem.2019.07.010_bb0465","first-page":"72","article-title":"DNA methylation patterns associated with oxidative stress in an ageing population","volume":"9","author":"Hedman","year":"2016","journal-title":"BMC Med. Genet."},{"issue":"1","key":"10.1016\/j.clinbiochem.2019.07.010_bb0470","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.canlet.2008.02.026","article-title":"Oxidative stress DNA methylation and carcinogenesis","volume":"266","author":"Franco","year":"2008","journal-title":"Cancer Lett."},{"issue":"3","key":"10.1016\/j.clinbiochem.2019.07.010_bb0475","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1096\/fj.09-144410","article-title":"Paraoxonase 1 protects against protein N-homocysteinylation in humans","volume":"24","author":"Per\u0142a-Kaj\u00e1n","year":"2010","journal-title":"FASEB J."},{"issue":"2","key":"10.1016\/j.clinbiochem.2019.07.010_bb0480","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1089\/ars.2012.4600","article-title":"Phytochemical antioxidants modulate mammalian cellular epigenome: implications in health and disease","volume":"17","author":"Malireddy","year":"2012","journal-title":"Antioxid. Redox Signal."},{"issue":"1","key":"10.1016\/j.clinbiochem.2019.07.010_bb0485","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.nut.2014.04.011","article-title":"Dietary polyphenols regulate endothelial function and prevent cardiovascular disease","volume":"31","author":"Yamagata","year":"2015","journal-title":"Nutrition"},{"issue":"1","key":"10.1016\/j.clinbiochem.2019.07.010_bb0490","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1007\/s00394-017-1394-2","article-title":"Daily supplementation with fresh pomegranate juice increases paraoxonase 1 expression and activity in mice fed a high-fat diet","volume":"57","author":"Estrada-Luna","year":"2018","journal-title":"Eur. J. Nutr."},{"key":"10.1016\/j.clinbiochem.2019.07.010_bb0495","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jnutbio.2017.06.002","article-title":"Role of polyphenols and polyphenol-rich foods in the modulation of PON1 activity and expression","volume":"48","author":"Martini","year":"2017","journal-title":"J. Nutr. Biochem."},{"issue":"12","key":"10.1016\/j.clinbiochem.2019.07.010_bb0500","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1021\/acs.chemrestox.6b00413","article-title":"Dietary phytochemicals and cancer chemoprevention: a perspective on oxidative stress, inflammation, and epigenetics","volume":"29","author":"Li","year":"2016","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.clinbiochem.2019.07.010_bb0505","series-title":"Identification of microRNA Biomarkers in Type 2 Diabetes: A Meta-Analysis of Controlled Profiling Studies","author":"Zhu","year":"2015"},{"issue":"4","key":"10.1016\/j.clinbiochem.2019.07.010_bb0510","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1093\/cvr\/cvr300","article-title":"Role of microRNAs in diabetes and its cardiovascular complications","volume":"93","author":"Shantikumar","year":"2011","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.clinbiochem.2019.07.010_bb0515","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.atherosclerosis.2017.12.022","article-title":"Genetic polymorphisms offer insight into the causal role of microrna in coronary artery disease","volume":"269","author":"Borghini","year":"2018","journal-title":"Atherosclerosis"},{"issue":"2","key":"10.1016\/j.clinbiochem.2019.07.010_bb0520","doi-asserted-by":"crossref","first-page":"e149","DOI":"10.1111\/sms.12421","article-title":"Circulating microRNAs in response to exercise","volume":"25","author":"Xu","year":"2015","journal-title":"Scand. J. Med. Sci. Sports"},{"issue":"D1","key":"10.1016\/j.clinbiochem.2019.07.010_bb0525","doi-asserted-by":"crossref","first-page":"D155","DOI":"10.1093\/nar\/gky1141","article-title":"miRBase: from microRNA sequences to function","volume":"47","author":"Kozomara","year":"2018","journal-title":"Nucleic Acids Res."},{"issue":"9","key":"10.1016\/j.clinbiochem.2019.07.010_bb0530","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1038\/nrendo.2013.86","article-title":"Circulating microRNAs as novel biomarkers for diabetes mellitus","volume":"9","author":"Guay","year":"2013","journal-title":"Nat. Rev. Endocrinol."},{"issue":"5","key":"10.1016\/j.clinbiochem.2019.07.010_bb0535","doi-asserted-by":"crossref","first-page":"8280","DOI":"10.1002\/jcb.28111","article-title":"A panel of noncoding RNAs in non\u2013small-cell lung cancer","volume":"120","author":"Bagheri","year":"2019","journal-title":"J. Cell. Biochem."},{"issue":"10","key":"10.1016\/j.clinbiochem.2019.07.010_bb0540","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0140958","article-title":"MiR-486 and miR-92a identified in circulating HDL discriminate between stable and vulnerable coronary artery disease patients","volume":"10","author":"Niculescu","year":"2015","journal-title":"PLoS ONE"},{"key":"10.1016\/j.clinbiochem.2019.07.010_bb0545","doi-asserted-by":"crossref","first-page":"80","DOI":"10.3389\/fphys.2013.00080","article-title":"Muscle-enriched microRNA miR-486 decreases in circulation in response to exercise in young men","volume":"4","author":"Aoi","year":"2013","journal-title":"Front. Physiol."},{"issue":"8","key":"10.1016\/j.clinbiochem.2019.07.010_bb0550","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1016\/j.amjcard.2010.12.014","article-title":"Effect of exercise training on plasma levels and functional properties of high-density lipoprotein cholesterol in the metabolic syndrome","volume":"107","author":"Casella-Filho","year":"2011","journal-title":"Am. J. Cardiol."},{"issue":"5","key":"10.1016\/j.clinbiochem.2019.07.010_bb0555","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/S0022-2275(20)30113-9","article-title":"Paraoxonase1-192 polymorphism modulates the effects of regular and acute exercise on paraoxonase1 activity","volume":"43","author":"Tom\u00e1s","year":"2002","journal-title":"J. Lipid Res."},{"issue":"1","key":"10.1016\/j.clinbiochem.2019.07.010_bb0560","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.atherosclerosis.2013.01.036","article-title":"A functional polymorphism of PON1 interferes with microRNA binding to increase the risk of ischemic stroke and carotid atherosclerosis","volume":"228","author":"Liu","year":"2013","journal-title":"Atherosclerosis"},{"issue":"11","key":"10.1016\/j.clinbiochem.2019.07.010_bb0565","doi-asserted-by":"crossref","first-page":"899","DOI":"10.5414\/CP202500","article-title":"Relationship of microRNA 616 gene polymorphism with prognosis of patients with premature coronary artery disease","volume":"54","author":"Zhang","year":"2016","journal-title":"Int. J. Clin. Pharmacol. Ther."},{"issue":"4","key":"10.1016\/j.clinbiochem.2019.07.010_bb0570","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1159\/000487565","article-title":"Functional SNP in the 3\u2019UTR of PON1 is associated with the risk of calcific aortic valve stenosis via MiR-616","volume":"45","author":"Wang","year":"2018","journal-title":"Cell. Physiol. Biochem."},{"issue":"5","key":"10.1016\/j.clinbiochem.2019.07.010_bb0575","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1159\/000491062","article-title":"Identification of prognostic value of Rs3735590 polymorphism in 3\u2019-Untranslated region (3\u2019-UTR) of Paraoxonase 1 (PON-1) in chronic obstructive pulmonary disease patients who received coronary artery bypass grafting (CABG)","volume":"47","author":"Lv","year":"2018","journal-title":"Cell. Physiol. Biochem."}],"container-title":["Clinical Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009912019306538?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009912019306538?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T15:54:59Z","timestamp":1757865299000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009912019306538"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":115,"alternative-id":["S0009912019306538"],"URL":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2019.07.010","relation":{},"ISSN":["0009-9120"],"issn-type":[{"value":"0009-9120","type":"print"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The epigenetic regulation of paraoxonase 1 (PON1) as an important enzyme in HDL function: The missing link between environmental and genetic regulation","name":"articletitle","label":"Article Title"},{"value":"Clinical Biochemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2019.07.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}